Effects of antihypertensive drugs on central blood pressure in humans: A preliminary observation

American Journal of Hypertension

Volumn 26, Issue 8, 2013, Pages 1045-1052

  Agnoletti, Davide ^a,b   Zhang, Yi ^c   Borghi, Claudio ^b   Blacher, Jacques ^a   Safar, Michel E ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c TONGJI UNIVERSITY   (China)

Author keywords

Antihypertensive agents; Arterial stiffness; Blood pressure; Central blood pressure; Hypertension; Pressure amplification; Wave reflection

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CANDESARTAN; INDAPAMIDE; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CAROTID ARTERY; CENTRAL BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTPATIENT; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUSTAINED DRUG RELEASE; SYSTOLIC BLOOD PRESSURE; TONOMETRY;

ANTIHYPERTENSIVE AGENTS; ARTERIAL STIFFNESS; BLOOD PRESSURE; CENTRAL BLOOD PRESSURE; HYPERTENSION; PRESSURE AMPLIFICATION; WAVE REFLECTION.;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; AORTA; ARTERIAL PRESSURE; BENZIMIDAZOLES; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BRACHIAL ARTERY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INDAPAMIDE; MALE; MANOMETRY; MIDDLE AGED; PULSE WAVE ANALYSIS; TETRAZOLES; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84881633233     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt081     Document Type: Article

References (34)

1. Black HR. The paradigm has shifted, to systolic blood pressure. Hypertension 1999; 34:386-387.
2. Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, Wang J-G, Wilkinson IB, Williams B, Vlachopoulos C. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007; 50:154-160.
3. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimatos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effect of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009; 15:272-289.
4. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, Roman MJ, Safar ME, Segers P, Smulyan H. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009; 54:375-383.
5. Agnoletti D, Zhang Y, Salvi P, Borghi C, Topouchian J, Safar ME, Blacher J. Pulse pressure amplification, pressure waveform calibration and clinical applications. Atherosclerosis 2012; 224:108-112.
6. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, Salvi P, Smulyan H, Safar ME. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. JACC 2010; 55:1032-1037.
7. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735-738.
8. London G, Schmieder R, Calvo C, Asmar R. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. Am J Hypertens 2006; 19:113-121.
9. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38:932-937.
10. Kelly R, Karamanoglu M, Gibbs H, Avolio A, O'Rourke M. Noninvasive carotid pressure wave registration as an indicator of ascending aortic pressure. J Vasc Med Biol 1989; 1:241-247.
11. Fujii M, Yaginuma T, Takazawa K, Toshitaka N, Komatsu H, Katsuki T, Watabiki H, Kawada Y, Hosoda S. Non-invasive detection for wave reflection in the arterial system by using carotid pulse wave, and its clinical application. J Jpn Coll Angiol 1989; 29:545-551.
12. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26:485-490.
13. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90:2786-2796.
14. Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension 1993; 22:876-883.
15. Wei L, Zhang J. Analysis of data with imbalance in the baseline outcome variable for randomized clinical trials. Drug Inf J 2001; 35:1201-1214.
16. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50:197-203.
17. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90:2786-2796.
18. Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009; 54:409-413.
19. Manisty CH, Zambanini A, Parker KH, Davies JE, Francis DP, Mayet J, McG Thom SA, Hughes AD. Differences in the magnitude of wave reflection account for differential effects of amlodipine-versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy. Hypertension 2009; 54:724-730.
20. Mahmud A, Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens 2000; 14:541-546.
21. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006; 19:214-219.
22. Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension. Hypertension 2003; 41:297-301.
23. Aznaouridis KA, Stamatelopoulos KS, Karatzis EN, Protogerou AD, Papamichael CP, Lekakis JP. Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients. J Hum Hypertens 2007; 21:654-663.
24. Dart AM, Cameron JD, Gatzka CD, Willson K, Liang Y-L, Berry KL, Wing LMH, Reid CM, Ryan P, Beilin LJ, Jennings GLR, Johnston CI, McNeil JJ, Macdonald GJ, Morgan TO, West MJ, Kingwell BA. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007; 49:1242-1247.
25. Jiang XJ, O'Rourke MF, Zhang YO, He XY, Liu LS. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens 2007; 25:1095-1099.
26. Benetos A, Gautier S, Labat C, Salvi P, Valbusa F, Marino F, Toulza O, Agnoletti D, Zamboni M, Dubail D, Manckoundia P, Rolland Y, Hanon O, Perret-Guillaume C, Lacolley P, Safar ME, Guillemin F. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE study. JACC 2012; 60:1503-1511.
27. Sassard J, Bataillard A, McIntyre H. An overview of the pharmacology and clinical efficacy of indapamide sustained release. Fundam Clin Pharmacol 2005; 19:637-645.
28. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358:1887-1898.
29. Ichihara A, Kaneshiro Y, Sakoda M, Takemitsu T, Itoh H. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker. J Cardiovasc Pharmacol 2007; 49:161-166.
30. Benetos A, Levy B, Lacolley P, Taillard F, Duriez M, Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997; 17:3196-3201.
31. Labat C, Lacolley P, Lajemi M, De Gasparo M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in SHR under high salt diet. Hypertension 2001; 38:439-443.
32. Shargorodsky M, Hass E, Boaz M, Gavish D, Zimlichman R. High dose treatment with angiotensin II receptor blocker in patients with hypertension: differential effect of tissue protection versus blood pressure lowering. Atherosclerosis 2008; 197:303-310.
33. Spoelstra-de Man AME, van Ittersum FJ, Schram MT, Kamp O, van Dijk RAJM, Ijzerman RG, Twisk JWR, Brouwer CB, Stehouwer CDA. Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension. J Hum Hypertens 2006; 20:599-611.
34. London GM, Asmar RG, O'Rourke MF, Safar ME, on behalf of the REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43:92-99.